Explore the latest 8-K report from FibroGen Inc. (Ticker: FGEN) detailing significant corporate events. Stay informed about this NASDAQ-listed company's developments.
Explore Gyre Therapeutics, Inc.'s significant 8-K filing from February 14, 2025. Get insights on stock info, company details, and event-driven disclosures crucial for investors.
Explore the American Electric Power Company's 8-K filing from February 13, 2025, detailing stock info & corporate updates essential for investors.
Discover crucial insights from Li-Cycle Holdings Corp.'s 8-K filing, revealing significant events on January 13, 2025, impacting investors and stakeholders.
Explore Xeris Biopharma's latest 8-K filing detailing significant developments affecting stock performance. Stay informed on market movements and company updates.
Discover vital insights from Outset Medical, Inc.'s 8-K report, filed on January 7, 2025. Learn about recent developments impacting OM stock on NASDAQ.
Explore Benitec Biopharma Inc.'s amendment to Form 8-K filed on December 27, 2024, detailing important disclosures under Item 5.02. Learn more about the company and filing specifics.
Explore key insights from Supernus Pharmaceuticals Inc.'s 8-K filing, covering essential updates and financial data as of December 19, 2024. Essential for investors and analysts.
Explore Fox Corporation's 8-K filing from February 9, 2021. Discover stock class details, governance structure, and essential corporate information crucial for investors.